Vitruvias Therapeutics Inc. is voluntarily recalling nearly 2,000 bottles of Thyroid Tablets, USP, after the product was found to be superpotent, meaning the tablets contain more active ingredient than labeled — a potentially dangerous condition for patients.

Major Pharmaceuticals has voluntarily recalled multiple strengths and lot numbers of levothyroxine sodium tablets nationwide.